Apogee Therapeutics Inc. (APGE)
(Delayed Data from NSDQ)
$39.88 USD
+0.27 (0.68%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $39.86 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
APGE 39.88 +0.27(0.68%)
Will APGE be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for APGE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APGE
Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?
Wall Street Analysts See a 129.09% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?
APGE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Apogee Therapeutics Inc. (APGE) Could Surge 132.72%: Read This Before Placing a Bet
Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 134%: Here's is How to Trade
Other News for APGE
Upper Bollinger Band Walk appears for APGE after 0.68% move
Slingshot Bullish appears for APGE after 0.58% move
Canaccord Genuity Sticks to Their Buy Rating for Apogee Therapeutics (APGE)
APGE forms Shooting Star Candlestick on October 1
Is APGE poised for gains? 200 Day Moving Average Support shows up after sliding 0.25%